{"id":"NCT01308060","sponsor":"Galderma R&D","briefTitle":"A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET)","officialTitle":"A Multi-center Randomized, Double-blind, Placebo Controlled, Parallel-group Study of CD07743 for the Improvement of Lateral Canthal Lines (Crow's Feet)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2012-05","completion":"2012-05","firstPosted":"2011-03-03","resultsPosted":"2020-05-01","lastUpdate":"2020-05-01"},"enrollment":335,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Canthal Lines"],"interventions":[{"type":"DRUG","name":"Botulinum Toxin Type A","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Botulinum Toxin type A","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This double-blind study has two parts for each subject (same population):\n\nPart A: initial treatment in Lateral Canthal Lines (LCL) (placebo-controlled):\n\n* To assess the efficacy and safety of Azzalure® compared to placebo in the improvement of moderate to severe LCLs.\n* To assess the subjects' level of satisfaction with the appearance of their LCLs compared to placebo.\n\nPart B: repeated treatment in LCL with or without Glabellar Lines (GL) (active treatment, up to 1 year):\n\n* To assess safety of Azzalure® following repeated administration in the improvement of moderate to severe LCLs.\n* To assess the safety of Azzalure® when used concomitantly for improvement of moderate to severe LCLs and GLs.\n* To assess the subjects' level of satisfaction with the appearance of their LCLs.","primaryOutcome":{"measure":"Number of Responders on the Severity of Lateral Canthal Lines \"at Maximum Smile\".","timeFrame":"Week 4","effectByArm":[{"arm":"Botulinum Toxin Type A","deltaMin":119,"sd":null},{"arm":"Placebo","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":252},"commonTop":[]}}